Trademark: 87980019
Status Date
Tuesday, March 26, 2019
Registration Number
5708239
Registration Date
Tuesday, March 26, 2019
Filing Date
Monday, June 26, 2017
Published for Opposition
Tuesday, November 28, 2017
44 Providing on-line searchable databases featuring health-related information on spectral results of biomarkers used in the detection and treatment of disease; medical diagnostic, prognostic and predictive reporting services; medical services in the fields of cytology, histology and pathology; medical adjunctive and triage testing for diagnostic and treatment purposes; medical prognostic and diagnostic testing in the field of biomarkers for disease detection and treatment; medical screening, medical monitoring, and medical companion diagnostic testing services; medical services, namely, gene therapy design and delivery services in the fields of oncology, pathology, and biomarkers
42 Cloud computing for pathology and whole slide imaging featuring software for use in automated acquisition and analysis of images of human and animal cells and tissues, for use in entering, storing and analyzing data, for management of medical diagnostic, prognostic and predictive information by clinicians, research scientists and pathologists and other laboratory professionals in the fields of pathology, oncology, pharmaceutical drug and therapy development and whole slide imaging, data reporting, tissue bank sample management and test results archiving, with data archiving and retrieval features; providing databases in the field of spectral imaging information based on biomarkers for disease detection and treatment for scientific research purposes; providing an on-line searchable database in the field of pathology and the use of biomarkers for disease detection and treatment for scientific research purposes only; clinical laboratory providing biomarker research services; data mining of database featuring patient sample biomarkers; biomarker screening for scientific research purposes; pharmaceutical drug design; pharmaceutical research and development services in the fields of drug design and drug delivery; conducting clinical trials for others in the field of gene therapy design and delivery; pharmaceutical research and development in the field of gene therapy design and delivery; biomedical research in the field of gene therapy design and delivery; custom design and development of companion diagnostic tests and assays in the field of gene therapy design and delivery; and laboratory services, namely, archiving tissue and cell samples for use in the field of gene therapy design and delivery for research purposes
Mar 26, 2024
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Mar 26, 2019
Registered-Principal Register
Feb 20, 2019
1(B) Basis Deleted; Proceed To Registration
Jan 23, 2019
Notice Of Allowance Cancelled
Feb 20, 2019
Divisional Processing Complete
Jan 23, 2019
Divisional Request Received
Feb 20, 2019
Case Assigned To Intent To Use Paralegal
Jan 23, 2019
Teas Request To Divide Received
Jul 24, 2018
Notice Of Approval Of Extension Request E-Mailed
Jul 20, 2018
Sou Extension 1 Granted
Jul 20, 2018
Sou Extension 1 Filed
Jul 20, 2018
Sou Teas Extension Received
Jan 23, 2018
Noa E-Mailed - Sou Required From Applicant
Nov 28, 2017
Official Gazette Publication Confirmation E-Mailed
Nov 28, 2017
Published For Opposition
Nov 8, 2017
Notification Of Notice Of Publication E-Mailed
Oct 26, 2017
Law Office Publication Review Completed
Oct 20, 2017
Assigned To Lie
Oct 6, 2017
Approved For Pub - Principal Register
Sep 29, 2017
Examiner's Amendment Entered
Sep 29, 2017
Notification Of Examiners Amendment E-Mailed
Sep 29, 2017
Examiners Amendment E-Mailed
Sep 29, 2017
Examiners Amendment -Written
Sep 22, 2017
Assigned To Examiner
Jul 1, 2017
New Application Office Supplied Data Entered
Jun 29, 2017
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
